High-dose estrogen impairs demethylation of H3K27me3 by decreasing Kdm6b expression during ovarian hyperstimulation in mice.
- Author:
Quanmin KANG
1
;
Fang LE
1
;
Xiayuan XU
1
;
Lifang CHEN
1
;
Shi ZHENG
1
;
Lijun LOU
2
;
Nan JIANG
3
;
Ruimin ZHAO
1
;
Yuanyuan ZHOU
1
;
Juan SHEN
1
;
Minhao HU
1
;
Ning WANG
1
;
Qiongxiao HUANG
4
;
Fan JIN
5
Author Information
- Publication Type:Journal Article
- Keywords: Assisted reproductive technology (ART); Histone methylation; Ovarian stimulation
- MeSH: Female; Mice; Demethylation/drug effects*; Embryonic Stem Cells; Estrogens/administration & dosage*; Gene Expression/drug effects*; Histones/metabolism*; Jumonji Domain-Containing Histone Demethylases/metabolism*; Mice, Inbred C57BL; Oocytes; Ovary/drug effects*; Reproductive Techniques, Assisted; Animals
- From: Journal of Zhejiang University. Science. B 2025;26(3):269-285
- CountryChina
- Language:English
- Abstract: Given that ovarian stimulation is vital for assisted reproductive technology (ART) and results in elevated serum estrogen levels, exploring the impact of elevated estrogen exposure on oocytes and embryos is necessary. We investigated the effects of various ovarian stimulation treatments on oocyte and embryo morphology and gene expression using a mouse model and estrogen-treated mouse embryonic stem cells (mESCs). Female C57BL/6J mice were subjected to two types of conventional ovarian stimulation and ovarian hyperstimulation; mice treated with only normal saline served as controls. Hyperstimulation resulted in high serum estrogen levels, enlarged ovaries, an increased number of aberrant oocytes, and decreased embryo formation. The messenger RNA (mRNA)-sequencing of oocytes revealed the dysregulated expression of lysine-specific demethylase 6b (Kdm6b), which may be a key factor indicating hyperstimulation-induced aberrant oocytes and embryos. In vitro, Kdm6b expression was downregulated in mESCs treated with high-dose estrogen; treatment with an estrogen receptor antagonist could reverse this downregulated expression level. Furthermore, treatment with high-dose estrogen resulted in the upregulated expression of histone H3 lysine 27 trimethylation (H3K27me3) and phosphorylated H2A histone family member X (γ-H2AX). Notably, knockdown of Kdm6b and high estrogen levels hindered the formation of embryoid bodies, with a concomitant increase in the expression of H3K27me3 and γ-H2AX. Collectively, our findings revealed that hyperstimulation-induced high-dose estrogen could impair the demethylation of H3K27me3 by reducing Kdm6b expression. Accordingly, Kdm6b could be a promising marker for clinically predicting ART outcomes in patients with ovarian hyperstimulation syndrome.
